Overexpression of p53 protein in gallbladder carcinoma in North India

European Journal of Surgical Oncology

Volumn 26, Issue 2, 2000, Pages 164-167

  Misra, S ^a   Chaturvedi, A ^a   Goel, M M ^a   Mehrotra, R ^a   Sharma, I D ^a   Srivastava, A N ^a   Misra, N C ^a  

^a KING GEORGE'S MEDICAL UNIVERSITY   (India)

Author keywords

Gallbladder cancer; Immunohistochemistry; p53

Indexed keywords

PROTEIN P53;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; GALLBLADDER CARCINOMA; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INDIA; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0034093568     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1053/ejso.1999.0763     Document Type: Article

References (32)

1. Indian Council of Medical Research (ICMR), Annual report of population based cancer registries of the National Cancer Registry Programme (1993). New Delhi: ICMR Publication, 1996: 18.
2. Misra, NC, Misra, S, Chaturvedi, A, Carcinoma of the gallbladder. In: Johnson CD, Taylor I (Eds), Recent Advances in Surgery Vol. 20, London: Churchill Livingstone, 1997: 69-87.
3. Vogelstein B. Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. Science. 244:1989;217-221.
4. Harris AL. Mutant p53: the commonest genetic abnormality in human cancer. J Pathol. 162:1990;50-56.
5. Chang F, Syrjanen S, Tervahauta A, Syrjanen K. Tumorigenesis associated with the p53 tumour suppressor gene. Br J Cancer. 68:1993;653-661.
6. Chang F, Syrjanen S, Syrjanen K. Implication of the p53 tumor-suppressor gene in clinical oncology. J Clin Oncol. 13:1995;1009-1022.
7. Bartek J, Bartkova J, Lukas J, Staskovas Z, Vojtesek B, Lane DP. Immunohistochemical analysis of the p53 oncoprotein on paraffin sections using a series of novel monoclonal antibodies. J Pathol. 169:1993;27-34.
8. Porter PL, Gown AM, Kramp SG, Coltrera MD. Widespread p53 overexpression in human malignant tumors. Am J Pathol. 140:1992;145-153.
9. Kamel D, Paakko P, Nourva K, Vahakangas K, Soni Y. p53 and c-erb B-2 protein expression in adenocarcinomas and epithelial dysplasias of the gallbladder. J Pathol. 170:1993;67-72.
10. Teh M, Wee A, Raju GC. An immunohistochemical study of p53 protein in gallbladder and extrahepatic bile duct/ampullary carcinomas. Cancer. 74:1994;1542-1545.
11. Diamantis I, Karamitopoulou E, Perentes E, Zimmerman A. p53 protein immunoreactivity in extrahepatic bile duct and gallbladder cancer; correlation with tumor grade and survival. Hepatology. 22:1995;774-779.
12. Ajiki T, Onoyama H, Yamamoto M et al. p53 protein expression and prognosis in gallbladder carcinoma and premalignant lesions. Hepato-Gastroenterol. 43:1996;521-526.
13. Fujii K, Yokozaki H, Yasui W et al. High frequency of p53 gene mutation in adenocarcinomas of the gallbladder. Cancer Epidemiol Biomarkers & Prevention. 5:1996;461-466.
14. Wistuba II, Gazdar AF, Roa I, Albores-Saavedra J. p53 protein overexpression in gallbladder carcinoma and its precursor lesions: an immunohistochemical study. Hum Pathol. 27:1996;360-365.
15. Itoi T, Watanabe H, Yoshida M, Ajioka Y, Nishikura K, Saito T. Correlation of p53 protein expression with gene mutation in gall-bladder carcinomas. Pathol Int. 47:1997;525-530.
16. Roa I, Villaseca M, Araya J et al. p53 tumour suppressor gene protein expression in early and advanced gallbladder carcinoma. Histopathology. 31:1997;226-230.
17. Roa I, Villaseca M, Araya JC et al. DNA ploidy pattern and tumor suppressor gene p53 expression in gallbladder carcinoma. Cancer Epidemiol Biomarkers & Prevention. 6:1997;547-550.
18. Albores-Saavedra J, Henson D, Sobin LH. The WHO histological classification of tumors of the gallbladder and extrahepatic bile ducts. Cancer. 70:1992;410-414.
19. Oohashi Y, Watanabe H, Ajioka Y, Hatakeyama K. p53 immunostaining distinguishes malignant from benign lesions of the gallbladder. Pathol Int. 45:1995;58-65.
20. Wee A, Teh M, Raju GC. Clinical importance of p53 protein in gallbladder carcinoma and its precursor lesions. J Clin Pathol. 47:1994;453-456.
21. Bodner SM, Minna JD, Jensen SM et al. Expression of mutant p53 proteins in lung cancer correlates with the class of p53 gene mutation. Oncogene. 7:1992;743-749.
22. Kennedy SM, Macgeogh C, Jaffe R, Spurr NK. Overexpression of the oncoprotein p53 in primary hepatic tumours of childhood does not correlate with mutations. Hum Pathol. 25:1994;438-442.
23. Cordon-Cardo C, Dalbagni G, Saez GT et al. p53 mutations in human bladder cancer: Genotypic versus phenotypic patterns. Int J Cancer. 56:1994;347-353.
24. Yokoyama N, Hitomi J, Watanabe H et al. Mutations of p53 in gallbladder carcinomas in high-incidence areas of Japan and Chile. Cancer Epidemiol iomarkers & Prevention. 7:1998;297-301.
25. Muto Y, Sho Y, Kurihara K et al. Morphological study of carcinoma of the gallbladder its differences between calculous and acalculous carcinoma. J Jpn Surg Soc. 86:1985;846-852.
26. Westra WH, Offerhaus GJA, Goodman SN et al. Overexpression of the p53 tumor suppressor gene product in primary lung adenocarcinomas is associated with cigarette smoking. Am J Surg Pathol. 17:1993;213-220.
27. Soini Y, Paakko P, Nuorva K, Kamel D, Lane DP, Vahakangas K. Comparative analysis of p53 protein immunoreactivity in prostatic, lung and breast carcinomas. Virchows Arch [A]. 421:1992;223-228.
28. Esrig D, Spruck CH, Nichols PW et al. p53 nuclear protein accumulation correlates with mutations in the p53 gene, tumor grade, and stage in bladder cancer. Am J Pathol. 143:1993;1389-1397.
29. Starzynska T, Bromley M, Ghosh A, Stern PL. Prognostic significance of p53 overexpression in gastric and colorectal carcinoma. Br J Cancer. 66:1992;558-562.
30. Martin HM, Filipe MI, Morris RW, Lane DP, Silvestre F. p53 expression and prognosis in gastric carcinoma. Int J Cancer. 50:1992;859-862.
31. Lee CS. Ras p21 protein immunoreactivity and its relationship to p53 expression and prognosis in gallbladder and extrahepatic biliary carcinoma. Eur J Surg Oncol. 23:1997;233-237.
32. Wistuba II, Sugio K, Hung J et al. Allele-specific mutations involved in the pathogenesis of endemic gallbladder carcinoma in Chile. Cancer Res. 55:1995;2511-2515.